RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: NO ADVERSE EVENT

20250101 - 20251231

No. 701 - 800

Next page: 9 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
701
25087954
US
 62 2
Off label use, No adverse event,
TOCILIZUMAB,
702
25088014
US
 1
No adverse event, Product administration error,
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB,
703
25088027
US
 69
Drug dose omission by device, Wrong technique in product usage process, No adverse event,
ALBUTEROL SULFATE,
704
25088045
US
Recalled product administered, No adverse event,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
705
25088078
US
Product dose omission issue, Product complaint, No adverse event,
706
25088096
US
Recalled product administered, No adverse event,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
707
25088117
US
 51 1
Off label use, No adverse event,
OMALIZUMAB,
708
25088154
US
 12
Accidental overdose, No adverse event,
709
25088196
US
 11 1
Off label use, No adverse event,
OMALIZUMAB,
710
25088198
US
Off label use, No adverse event,
EMICIZUMAB,
711
25088231
US
 1
Off label use, No adverse event, Drug ineffective, Off label use,
OMALIZUMAB, OMALIZUMAB,
712
25088418
US
Asthenia, Hot flush, No adverse event,
RELUGOLIX, RELUGOLIX, AMLODIPINE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE,
713
25088821
US
 33 2
Expired product administered, No adverse event,
714
25089037
US
 25 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
715
25089109
GB
 63 2
No adverse event,
DENOSUMAB, FULVESTRANT, RIBOCICLIB,
716
25089221
US
 2
Underdose, Product physical issue, Wrong technique in product usage process, No adverse event,
717
25089272
US
 75
Product storage error, Device malfunction, Wrong technique in product usage process, No adverse event,
ALBUTEROL SULFATE,
718
25089288
US
 2
Extra dose administered, No adverse event,
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE,
719
25089293
US
Drug ineffective, No adverse event,
720
25089610
US
 32 2
Off label use, No adverse event,
OMALIZUMAB,
721
25089653
US
 22 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
722
25089810
US
 54 2
Product dispensing error, No adverse event,
OCRELIZUMAB,
723
25089916
US
 62 2
Off label use, No adverse event,
TOCILIZUMAB,
724
25090368
US
Exposure during pregnancy, No adverse event,
725
25090370
US
Exposure during pregnancy, No adverse event,
EMTRICITABINE,
726
25090409
US
Off label use, No adverse event,
RITUXIMAB,
727
25090683
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
728
25090684
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
729
25090716
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
730
25090866
US
 2
Device infusion issue, Incorrect dose administered, Off label use, No adverse event,
731
25090964
US
 43 1
No adverse event,
NALTREXONE,
732
25090967
US
 2
Product dose omission issue, No adverse event,
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK,
733
25091157
US
Product dispensing error, No adverse event,
FIDAXOMICIN,
734
25091292
DE
Device malfunction, No adverse event,
ENOXAPARIN SODIUM,
735
25091641
US
 1
No adverse event,
INSULIN GLARGINE,
736
25091925
JP
 4 1
Drug ineffective, No adverse event,
737
25081997
US
Off label use, No adverse event, Off label use,
BEVACIZUMAB,
738
25082056
US
 4 2
Off label use, No adverse event,
OMALIZUMAB,
739
25082105
US
 2
Intentional product misuse, No adverse event,
OMALIZUMAB, OMALIZUMAB, OIL, BIOTIN, HAIR, CALCIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ERGOCALCIFEROL,
740
25082160
US
 78 2
Product storage error, No adverse event,
TOCILIZUMAB, CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN,
741
25082162
US
Product storage error, No adverse event,
TOCILIZUMAB, TOCILIZUMAB,
742
25082229
US
 12 2
Product storage error, No adverse event,
743
25082282
US
 9 1
Off label use, No adverse event,
OMALIZUMAB,
744
25082708
PA
 76 2
No adverse event,
AGALSIDASE BETA,
745
25082748
US
 9
Prescribed underdose, No adverse event,
TENECTEPLASE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE,
746
25082841
US
 1
No adverse event, Product dose omission in error,
747
25082856
US
Product storage error, No adverse event,
RISDIPLAM,
748
25082904
US
 15 2
Product dispensing error, Device issue, No adverse event,
OMALIZUMAB, OMALIZUMAB, FAMOTIDINE, METHYLPHENIDATE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE, DEXMETHYLPHENIDATE HYDROCHLORIDE,
749
25082927
US
 1
Drug ineffective, No adverse event,
OMALIZUMAB, OMALIZUMAB,
750
25082930
US
Product temperature excursion issue, No adverse event,
OMALIZUMAB,
751
25082931
US
Product storage error, No adverse event,
OMALIZUMAB,
752
25082934
US
 2
Drug ineffective, No adverse event,
OMALIZUMAB, OMALIZUMAB,
753
25082964
JP
 70 1
No adverse event,
PEGFILGRASTIM, FILGRASTIM, RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, PLERIXAFOR,
754
25083050
US
Recalled product administered, No adverse event,
RAMIPRIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
755
25083174
US
No adverse event,
ISTRADEFYLLINE, VALBENAZINE,
756
25083516
US
 8 2
Off label use, No adverse event,
TOCILIZUMAB, TOCILIZUMAB,
757
25083660
US
Device delivery system issue, Drug dose omission by device, No adverse event,
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE,
758
25083783
US
 53 2
Product dose omission issue, Wrong technique in product usage process, Product packaging issue, No adverse event,
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB,
759
25083898
US
Product dispensing issue, No adverse event,
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE),
760
25083934
US
Drug dose omission by device, Wrong technique in product usage process, Product use in unapproved indication, No adverse event,
ALBUTEROL SULFATE,
761
25083974
US
 59 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
762
25083977
US
 61
Drug dose omission by device, Wrong technique in product usage process, Device malfunction, No adverse event,
ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
763
25083993
US
 70
Device delivery system issue, Drug dose omission by device, No adverse event,
ALBUTEROL SULFATE,
764
25084010
US
 2
Product storage error, No adverse event,
OMALIZUMAB, OMALIZUMAB,
765
25084143
US
Expired product administered, Device delivery system issue, No adverse event,
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE,
766
25084314
US
Recalled product administered, No adverse event,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
767
25084367
US
 2
Off label use, No adverse event,
TOCILIZUMAB, APIXABAN, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, TIZANIDINE,
768
25084440
US
Intercepted product storage error, No adverse event,
ALTEPLASE,
769
25084560
US
 1
Product administration error, No adverse event,
VISMODEGIB, VISMODEGIB,
770
25084721
US
Recalled product administered, No adverse event,
RAMIPRIL,
771
25085257
US
 79
Expired product administered, Recalled product administered, No adverse event,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
772
25085376
US
 33 2
Maternal exposure before pregnancy, No adverse event, Maternal exposure during pregnancy,
OCRELIZUMAB,
773
25085382
US
Drug dose omission by device, Device delivery system issue, No adverse event,
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE,
774
25085441
US
Recalled product administered, No adverse event,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
775
25085504
US
 38 2
Off label use, No adverse event,
OBINUTUZUMAB,
776
25085668
US
No adverse event, Product distribution issue, Product storage error,
VEDOLIZUMAB,
777
25085836
US
 1
Product knowledge deficit, No adverse event, Drug delivery system malfunction,
OMALIZUMAB,
778
25085884
US
 2
Off label use, No adverse event,
BEVACIZUMAB,
779
25086596
US
 79 2
Product dose omission issue, No adverse event,
PEMBROLIZUMAB,
780
25081356
US
 15 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
781
25081525
US
Recalled product administered, No adverse event,
RAMIPRIL,
782
25080367
US
 39 2
Off label use, No adverse event,
TOCILIZUMAB,
783
25080540
US
 59 1
No adverse event,
TIRZEPATIDE,
784
25080808
US
 17 1
Off label use, Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
785
25080925
US
 70 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
786
25081159
US
Device delivery system issue, No adverse event,
GLUCAGON,
787
25081171
JP
Drug dose omission by device, No adverse event, Device delivery system issue,
GLUCAGON, DIPYRIDAMOLE, PAROXETINE HYDROCHLORIDE, INSULIN LISPRO, ROSUVASTATIN,
788
25076977
US
Accidental overdose, No adverse event,
PEMBROLIZUMAB,
789
25077000
US
Medication error, No adverse event,
POLATUZUMAB VEDOTIN,
790
25077009
US
 62 2
Off label use, No adverse event,
OMALIZUMAB,
791
25077193
US
 83 2
No adverse event,
TERIPARATIDE,
792
25077225
CN
 1
No adverse event,
PRALSETINIB, PRALSETINIB,
793
25077238
US
 23 2
Product dose omission issue, Product complaint, Device failure, No adverse event,
OMALIZUMAB,
794
25077276
US
 2
Wrong technique in product usage process, Product complaint, No adverse event,
795
25077714
US
No adverse event, Product availability issue, Product use issue,
LISDEXAMFETAMINE DIMESYLATE,
796
25077899
HR
 27 1
Suicide attempt, No adverse event, Intentional overdose,
AMLODIPINE,
797
25077997
US
 14 2
Off label use, No adverse event,
OMALIZUMAB,
798
25078129
US
 2
Off label use, No adverse event,
BEVACIZUMAB, TRIFLURIDINE AND TIPIRACIL,
799
25078142
US
 66 1
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
800
25078213
US
 2
No adverse event, Product colour issue, Product odour abnormal,
VORTIOXETINE, VORTIOXETINE, DIAZEPAM, DIAZEPAM,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2025-04-28

Next page: 9 next page>>